摘要
ST2 is a member of the interleukin-1 receptor family biomarker and circulating soluble ST2 concentrations are believed to reflect cardiovascular stress and fibrosis. Recent studies have demonstrated soluble ST2 to be a strong predictor of cardiovascular outcomes in both chronic and acute heart failure. It is a new biomarker that meets all required criteria for a useful biomarker. Of note, it adds information to natriuretic peptides (NPs) and some studies have shown it is even superior in terms of risk stratification. Since the introduction of NPs, this has been the most promising biomarker in the field of heart failure and might be particularly useful as therapy guide.
学科与关键词
关键词
Heart Failure / therapyBiomarkers, PharmacologicalReceptors, InterleukinPrognosis
- A Review of Novel Cardiac Biomarkers in Acute or Chronic Cardiovascular Diseases: The Role of Soluble ST2 (sST2), Lipoprotein-Associated Phospholipase A2 (Lp-PLA2), Myeloperoxidase (MPO), and Procalcitonin (PCT)Li, Junpei; Cao, Tianyu; Wei, Yaping; Zhang, Nan; Zhou, Ziyi; Wang, Zhuo; Li, Jingyi; Zhang, Yue; Wang, Sijia; Wang, Ping; Cheng, Nannan; Ye, Lijing; Li, Minghui; Yu, Yu; Ding, Congcong; Tan, Ziheng; Zhan, Biming; He, Qiangqiang; Bao, Huihui; Wu, Yanqing; Liu, Lishun; Li, Jianping; Xu, Xiping; Cheng, Xiaoshu; Huang, Xiao*DISEASE MARKERS, 2021, 2021: 6258865.被引 10
- Usefulness of cardiac biomarkers for prognosis of better outcomes in chronic heart failureGideon, Charach; Itamar, Grosskopf; Leonid, Galin; Eyal, Robinson; Roy, Hershenson; Lior, CharachMedicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2021, 100(5): e23464.
- Cardiomyocyte-Specific Cell-Free DNA as a Heart Failure Biomarker?Yvan DevauxCanadian Journal of Cardiology, 2020, 36(6): 807-808.
